The Role of Colchicine in Reducing The Rate of Myocardial Reperfusion Injury
Reperfusion Injury, Myocardial
About this trial
This is an interventional treatment trial for Reperfusion Injury, Myocardial focused on measuring Myocardial reperfusion injury, Colchicine
Eligibility Criteria
Inclusion Criteria: Patients diagnosed with ST-elevation myocardial infarction based on clinical symptoms, signs, and electrocardiography who undergo primary percutaneous coronary intervention Patients aged 18 - 80 years old Exclusion Criteria: Patients with malignancy Patients with allergic reaction to colchicine Stroke within the last 3 months Severe infection (sepsis) Chronic kidney disease with eGFR of <30mL/min/1.73m2
Sites / Locations
- Fakultas Kedokteran Universitas Indonesia
Arms of the Study
Arm 1
Arm 2
Experimental
Placebo Comparator
Colchicine
Placebo
Patients in the intervention group receive loading dose of colchicine 1 x 2 mg followed by colchicine 2 x 0,5 mg daily for two consecutive days.
Patients in the control group receive loading dose of placebo (lactose) 1 x 2 mg followed by lactose 2 x 0,5 mg daily for two consecutive days.